Skip to content

IQVIA IQV Commercial Solutions — Revenue

Other segment segments

Research & Development Solutions
$2.4B+6.2%

Similar metrics at other companies

Veeva Systems logo
VEEVCommercial Solutions — Total revenues
$337.87M+10.6%
Huron Consulting Group logo
HURNCommercial — Revenue
$92.97M+22.6%
Envela logo
ELACommercial — Revenue
$16.59M+44.4%
Transcontinental Realty Investors logo
TCICommercial Segment — Revenue
$3.91M+20.5%
Simulations Plus logo
SLPCommercialization — Revenue
$2.28M-2.9%
St. Joe Company logo
JOECommercial — Revenue
$17.42M-10.6%

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$32.25B+17.5%
Enterprise value$46.37B+12.8%
P/E23.3×+1.1×
P/S1.9×+0.2×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's commercial solutions — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's commercial solutions — revenue?
IQVIA (IQV) reported commercial solutions — revenue of $1.75B in Q1 2026.
What does commercial solutions — revenue mean?
This metric represents the total revenue generated by the Commercial Solutions business segment, which provides outsourced sales, marketing, and commercialization services to healthcare and pharmaceutical clients. It reflects the segment's ability to capture market demand for commercial support and product launch services.